ERBB2 and breast cancer: Hormone receptors (HRs), including estrogen receptors (ERs), progesterone receptors (PRs), human epidermal growth factor receptor 2 (HER2), and androgen receptor (AR), are basic histological and molecular biomarkers used for the diagnosis and evaluation of therapeutic responses in female and male BC [50].